Table 4 Relationship between having a positive catheter tip culture or catheter-related bacteremia and patient risk factors, or those related to the technique.

From: Assessing infection related to short-term central venous catheters in the perioperative setting

 

Catheter tip culture

OR (95% CI) or md (95% CI)

p

CLABSI

(N = 7)

OR (95% CI) or md (95% CI)

p

Positive

(n = 19)

Negative

(N = 179)

Male gender, n (%)

17 (89.5)

106 (59.2)

0.43 (0.15–1.24)

0.053

6 (85.7)

1.06 (1.01–1.11)

0.180

Age, years

63.2 ± 14.7

61.1 ± 12.9

1.67 (−4.54–7.87)

0.562

71.6 ± 7.4

10.28 (0.48–20.08)

0.008

Age > 60 years old, n (%)

16 (84.2)

111 (62.0)

1.09 (0.43–2.74)

0.202

7 (100)

0.95 (0.91–0.99)

0.041

BMI, kg·m−2

28.6 ± 3.8

28.8 ± 4.9

−0.12 (−2.41–2.16)

0.820

26.4 ± 0.7

−2.34 (−5.97–1.29)

0.212

BMI > 35 kg·m−2, n (%)

1 (5.2)

23 (12.8)

2.45 (0.34–17.56)

0.342

1 (14.3)

0.96 (0.93–1.99)

0.335

Neck circumference > 40 cm, n (%)

2 (10.5)

32 (17.9)

1.09 (0.34–3.54)

0.335

2 (28.6)

1.23 (1.53–9.88)

0.407

Smokers, n (%)

4 (21.0)

56 (31.3)

1.53 (0.53–4.42)

0.422

2 (28.6)

0.54 (0.13–2.36)

0.980

Cancer, n (%)

17 (89.5)

98 (54.7)

1.48 (1.18–2.29)

0.022

7 (100)

1.09 (1.04–1.84)

0.021

Diabetes mellitus, n (%)

6 (31.6)

38 (21.2)

0.79 (0.30–2.07)

0.442

2 (28.6)

0.70 (0.14–3.51)

0.669

COPD/Asthma, n (%)

4 (21.0)

28 (16.6)

1.02 (0.31–3.28)

0.687

2 (28.6)

1.14 (0.14–9.17)

0.356

Ischemic heart disease, n (%)

6 (31.6)

19 (10.6)

0.31 (0.13–0.74)

0.019

1 (14.3)

0.96 (0.93–0.99)

0.884

Immunosuppression, n (%)

0 (0)

18 (10.0)

0.89 (0.85–0.94)

0.128

0 (0)

0.96 (0.93–0.99)

0.397

Chronic kidney disease, n (%)

0 (0)

16 (8.9)

0.89 (0.85–0.94)

0.153

0 (0)

0.96 (0.93–0.99)

0.427

Cardiac failure, n (%)

2 (10.5)

7 (3.9)

0.85 (0.13–5.67)

0.240

2 (28.6)

0.28 (0.04–2.11)

0.002

Transplantation, n (%)

0 (0)

4 (2.2)

0.90 (0.86–0.95)

0.489

0 (0)

0.96 (0.94–0.99)

0.700

Intraoperative bleeding, ml

200 ± 100

198 ± 151

2.21 (−66.63–71.05)

0.961

186 ± 56

−12.73 (−122.55–97.09)

0.827

Duration of surgery, min

156 ± 62

161 ± 67

15.98 (−36.73–26.32)

0.773

175 ± 66

15.22 (−35.04–65.49)

0.567

Intraoperative vasoactive support, n (%)

4 (21.0)

45 (25.9)

0.80 (0.28–2.29)

0.840

1 (14.3)

0.50 (0.06–4.05)

0.925

Intraoperative transfusion, n (%)

0 (0)

6 (3.3)

0.90 (0.86–0.94)

0.420

0 (0)

0.96 (0.94–0.99)

0.636

Resident doctor operator, n (%)

7 (36.8)

100 (55.9)

0.51 (0.21–1.23)

0.050

2 (28.6)

0.65 (0.15–2.84)

0.178

Left or right internal jugular veins, n (%)

19 (100)

159 (88.8)

1.12 (1.06–1.18)

0.019

7 (100)

1.04 (1.01–1.07)

0.369

Ultrasound-guided, n (%)

7 (36.8)

49 (27.4)

0.67 (0.28–1.61)

0.565

3 (42.8)

0.97 (0.19–4.87)

0.373

Cannulation longer than 10 min, n (%)

3 (15.8)

28 (16.6)

1.02 (0.32–3.30)

0.750

1 (14.3)

0.91 (0.11–7.29)

0.905

Need to change side, n (%)

3 (15.8)

11 (6.1)

0.40 (0.13–1.21)

0.167

0 (0)

0.96 (0.93–0.99)

0.460

Success after > 2 attempts, n (%)

2 (10.5)

31 (17.3)

0.82 (0.20–3.35)

0.379

2 (28.6)

1.17 (0.15–9.29)

0.379

Difficulty passing the guide, n (%)

2 (10.5)

19 (10.6)

1.00

(0.25–4.04)

0.093

0 (0)

0.96 (0.93–0.99)

0.582

Other postoperative complications, n (%)

0 (0)

10 (5.0)

1.11 (1.06–1.16)

0.293

0 (0)

1.04 (1.01–1.07)

0.537

  1. Data are expressed in absolute and relative frequencies or mean ± SD. CLABSI: central line-associated bloodstream infection. OR (95% CI): Odds Ratio (95% Confidence Interval); md (95% CI): mean differences (95% Confidence Interval).